Galectin Therapeutics Inc. (GALT) — Dilution Risk Analysis
Current Snapshot
Galectin Therapeutics Inc. (GALT) has a DilutionWatch score of 52/10 and is classified as HIGH risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 52/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
Recent filing forms in the source payload: FORM 4 2, XBRL 2.
| Form | Filed | Accession |
|---|---|---|
| Form 4 | 2026-07-31 | 0001133416-26-000065|0001694903|2026-07-31|M|31825235 |
| Form 4 | 2026-07-31 | 0001133416-26-000065|0001694903|2026-07-31|M|2550932 |
| xbrl | 2025-12-31 | xbrl-4963-xbrl_warrant |
| xbrl | 2021-04-16 | xbrl-4963-xbrl_convertible |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| Cash runway | 4 months | Source |
| Three-year share count growth | 63.06% | Source |
DilutionWatch Analysis
- Risk Level
- HIGH (Score: 52/10) Source
- Cash Runway
- 4 months Source
- Share Count Growth (3-Year)
- 63.06% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.